CoreCap Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.1K Buy
254
+17
+7% +$4.47K ﹤0.01% 1258
2026
Q1
$63.2K Buy
237
+1
+0.4% +$271 ﹤0.01% 1202
2025
Q4
$59.2K Sell
236
-2
-0.8% -$531 ﹤0.01% 1245
2025
Q3
$68.3K Sell
238
-7
-3% -$1.88K ﹤0.01% 1185
2025
Q2
$64.3K Sell
245
-3
-1% -$731 ﹤0.01% 1133
2025
Q1
$57.7K Buy
248
+15
+6% +$3.64K ﹤0.01% 1116
2024
Q4
$53.4K Buy
233
+9
+4% +$2.06K ﹤0.01% 1159
2024
Q3
$50.1K Buy
+224
New +$49.2K ﹤0.01% 1181
2022
Q4
$208K Buy
+1,027
New +$201K 0.01% 527
2022
Q3
Sell
-321
Closed -$65K 1392
2022
Q2
$65K Buy
+321
New +$68.4K 0.01% 851
2022
Q1
Sell
-2,238
Closed -$604K 1393
2021
Q4
$604K Buy
+2,238
New +$554K 0.04% 324

Other funds holding LH

CoreCap Advisors's LH Position: Q2 2026 in Review

CoreCap Advisors increased its Labcorp (LH) stake by 7.2% in Q2 2026, buying an estimated $4.47K and bringing the position to 254 shares worth $71.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

CoreCap Advisors first reported a position in LH in Q4 2021 and has held it in 11 quarters since. The position peaked at $604K in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • CoreCap Advisors held 254 shares of Labcorp worth $71.1K as of Q2 2026.
  • CoreCap Advisors bought 17 Labcorp shares in Q2 2026, an estimated $4.47K.
  • Labcorp made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1258 holding.
  • CoreCap Advisors first reported a position in Labcorp in Q4 2021 and has held it in 11 quarters since.
  • CoreCap Advisors's Labcorp position peaked at $604K in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.